Catch up on news and events from the medical aesthetic industry around the globe. Join the mailing list to get the latest updates, including free webinars, practice enhancement tips, educational resources, and more.
We are pleased to announce the launch of our new Advanced Connectivity Module (ACM) Revenue Share Program, powered by Venus Connect™ smart technology. Our new Revenue Share Program is a continuation of our commitment to offer industry partners access to cutting-edge aesthetic technology without the traditional barriers they may have encountered in the past.
The popularity of aesthetic procedures has exploded and shows no sign of leveling off. Discover three of the top five medical aesthetic treatment trends to watch in 2018 and gain access to our invaluable report.
On last week’s episode of the Real Housewives of Beverly Hills, the housewives took a well-earned break from their busy schedules for a glamorous spa day featuring treatments with Venus Legacy and Venus Versa, courtesy of SkinLab.
Venus Concept Ltd., a privately-held and innovative global aesthetic technology leader, is pleased to announce that is has entered into agreement to acquire NeoGraft Solutions' hair restoration business ("NeoGraft").
Venus Legacy™ was recently the star of a great segment from Los Angeles’ KTLA 5 News, featuring Dr. Julius Few from the Few Institute for Aesthetic Plastic Surgery in Chicago. In this clip, titled Slim in the Spotlight, Dr. Few showcases...
As a medical aesthetics practitioner you know stretch marks are frustratingly difficult to treat. But recent academic research is pointing to a promising treatment. A study published in the Journal of Cosmetic Dermatology evaluated Venus Viva™ for treatment of striae alba, the chronic form of stretch marks.
For more information call: (888) 907-0115 // firstname.lastname@example.org
REGULATORY CLEARANCES [ More ]
Venus Versa™ is cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions, benign cutaneous vascular lesions, removal of unwanted hair, treatment of acne vulgaris, dermatological procedures requiring ablation and resurfacing of the skin, and non-invasive treatment of moderate to severe wrinkles and rhytides.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides and temporary reduction in the appearance of cellulite.
Venus Velocity™ is cleared by the FDA for hair removal, permanent hair reduction, and the treatment of pseudofolliculitis barbae.
Venus Viva™ is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides.